Literature DB >> 22020423

MR-diffusion imaging in assessing chronic liver diseases: does a clinical role exist?

F Pasquinelli1, G Belli, L N Mazzoni, F Regini, C Nardi, L Grazioli, A L Zignego, A Linda Zignego, S Colagrande.   

Abstract

PURPOSE: This study was done to evaluate whether and which of the magnetic resonance diffusion-weighted imaging (MR-DWI) parameters - apparent diffusion coefficient (ADC), diffusion (D) or perfusion fraction (f) - correlates with the degree of chronic liver disease progression.
MATERIALS AND METHODS: Twenty-eight patients were evaluated with abdominal MR-DWI from March to November 2010: seven healthy volunteers, seven patients with chronic liver disease F0-F2 (METAVIR score), seven F3-F4 Child-Pugh A, and seven F4 Child-Pugh BC, classified as groups 1-4, respectively. DWI acquisitions were performed during breath-holding (b = 0-150 s/mm(2) and 1,000) and free breathing (multi-b = 0-200-400-600-800-1,000 s/mm(2)). Using a double-blind control procedure, two observers estimated ADC, D, and f by applying a region of interest (ROI) in 4/12 sections in the middle-lower portion of the right hepatic lobe. Statistical analysis was done with analysis of variance (ANOVA).
RESULTS: A reduction in the mean value of f, ADC(150) and, to a lesser extent, ADC(1,000) is shown to progress from healthy volunteers (group 1) to cirrhosis patients (group 4), with wide overlap among groups. There were no statistically significant changes of D.
CONCLUSIONS: Our results indicate that stratifying patients with chronic liver disease for clinical purposes cannot be done with DWI. However, there is a tendency among groups for reduced perfusion-related parameters as chronic liver disease progresses.

Entities:  

Mesh:

Year:  2011        PMID: 22020423     DOI: 10.1007/s11547-011-0730-5

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  39 in total

1.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

3.  The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study.

Authors:  Seung Up Kim; Hui Won Jang; Jae Youn Cheong; Ja Kyung Kim; Myung Hee Lee; Dong Joon Kim; Jin Mo Yang; Sung Won Cho; Kwan Sik Lee; Eun Hee Choi; Young Nyun Park; Kwang-Hyub Han
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

4.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease.

Authors:  T Kim; T Murakami; S Takahashi; M Hori; K Tsuda; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1999-08       Impact factor: 3.959

5.  Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience.

Authors:  Jignesh Patel; Eric E Sigmund; Henry Rusinek; Marcel Oei; James S Babb; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

6.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

7.  Assessment of diffusion-weighted MR imaging in liver fibrosis.

Authors:  Laurence Annet; Frank Peeters; Jorge Abarca-Quinones; Isabelle Leclercq; Pierre Moulin; Bernard E Van Beers
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

Review 8.  Liver fibrosis: from the bench to clinical targets.

Authors:  M Pinzani; K Rombouts
Journal:  Dig Liver Dis       Date:  2004-04       Impact factor: 4.088

Review 9.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

10.  Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study.

Authors:  Alain Luciani; Alexandre Vignaud; Madeleine Cavet; Jeanne Tran Van Nhieu; Ariane Mallat; Lucile Ruel; Alexis Laurent; Jean-François Deux; Pierre Brugieres; Alain Rahmouni
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

View more
  8 in total

1.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

2.  Progress in non-invasive detection of liver fibrosis.

Authors:  Chengxi Li; Rentao Li; Wei Zhang
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

3.  The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.

Authors:  Diana Feier; Csilla Balassy; Nina Bastati; Romana Fragner; Friedrich Wrba; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

4.  Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mohamed Khashaba; Ahmed Abdalla; Mohamed Bayomy; Tarek Barakat
Journal:  Radiol Med       Date:  2014-05-21       Impact factor: 3.469

Review 5.  Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Authors:  D Marti-Aguado; A Rodríguez-Ortega; A Alberich-Bayarri; L Marti-Bonmati
Journal:  Abdom Radiol (NY)       Date:  2020-08-28

6.  Accuracy of visual analysis vs. apparent diffusion coefficient quantification in differentiating solid benign and malignant focal liver lesions with diffusion-weighted imaging.

Authors:  R Girometti; M Del Pin; S Pullini; L Cereser; G Como; M Bazzocchi; C Zuiani
Journal:  Radiol Med       Date:  2012-09-17       Impact factor: 3.469

Review 7.  Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications.

Authors:  Stefano Palmucci; Giuseppina Cappello; Giancarlo Attinà; Giovanni Fuccio Sanzà; Pietro Valerio Foti; Giovanni Carlo Ettorre; Pietro Milone
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

8.  Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma.

Authors:  Hong-Lei Guo; Ling He; Yan-Cui Zhu; Kun Wu; Feng Yuan
Journal:  Onco Targets Ther       Date:  2018-02-28       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.